Business CytoReason to License Its IBD Disease Model to Sanofi in Expanded Multiyear, Multimillion Dollar… Nick J Adam Jan 24, 2023 TEL AVIV, Israel, Jan. 23, 2023 (GLOBE NEWSWIRE) -- CytoReason, a leader and pioneer in computational disease… Read More...
Business Pfizer extends collaboration with disease model co CytoReason Nick J Adam Sep 23, 2022 Israeli company CytoReason, a developer of computational disease models that assist in the design of… Read More...
